Norway OKs OTC antiviral salesTo ease response to the H1N1 pandemic, Norway is allowing over-the-counter sales of oseltamivir (Tamiflu) and zanamivir (Relenza), the Associated Press (AP) reported. The new policy starts tomorrow and is in effect until the middle of 2010. Norway has ordered 9.4 million doses of vaccine, but the manufacturer has reportedly not produced enough to meet demand.
(CIDRAP News) Though pandemic flu is circulating at low levels in many parts of the world, Thailand and some West African nations are reporting increased activity, and the virus is being edged out by influenza B in China and other Asian regions, with signs of westward spread, the World Health Organization (WHO) said today.
(CIDRAP News) The World Health Organization (WHO) yesterday reported moderately active pandemic influenza activity in parts of the tropical regions of Asia, the Americas, and Africa, as well as influenza B activity in much of East Asia.